BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy

Peters, Renata B.; Xavier, Janaína; Mondin, Thaíse C.; Cardoso, Taiane de A.; Ferreira, Fabiana B.; Teixeira, Liana; Gräeff, Kiane; Quevedo, Luciana de A.; Jansen, Karen; Souza, Luciano D.; Oses, Jean P.; Pinheiro, Ricardo T.; da Silva, Ricardo A.; Ghisleni, Gabriele.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 43(1): 22-28, Jan.-Feb. 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1153276

Documentos relacionados

  1. Interaction between HTR2A rs3125 and negative life events in suicide attempts among patients with major depressive disorder: a cross-sectional study.
  2. Exploring the genetic heterogeneity in major depression across diagnostic criteria.
  3. Induced Pluripotent Stem Cells (iPSCs) Technology: Potential Targets for Depression.
  4. Genetic Association of Butyrylcholinesterase with Major Depressive Disorder.
  5. Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses.
  6. Optogenetic and chemogenetic insights into the neurocircuitry of depression-like behaviour: A systematic review.
  7. Loneliness and depression: bidirectional mendelian randomization analyses using data from three large genome-wide association studies.
  8. Genotype-expression interactions for BDNF across human brain regions.
  9. BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy.
  10. Effect of 25-hydroxyvitamin D levels on the internalising dimension as a transdiagnostic risk factor: Mendelian randomisation study.